Speakers

Confirmed speakers:

Hugues Abriel                      (University of Berne, Switzerland)

Stephane Angers                (Donnelly Centre, University of Toronto, Canada)

Eilika Weber-Ban                (ETH Zurich, Switzerland)

Nenad Ban                           (ETH Zurich, Switzerland)

Marcus Bantscheff             (Senior Scientific Director at Cellzome, a GSK company, Heidelberg, Germany)

Michael Bergmann              (Medical University Vienna, Austria)

Ozren Bogdanovic              (Andalusian Centre for Developmental Biology, Seville, Spain)

Ivana Carev                         (Medils, Split, Croatia)

María Almuedo-Castillo      (Andalusian Centre for Developmental Biology, Seville, Spain)

Hans Clevers                       (Head of Roche Pharma Research and Early Development, Basel, Switzerland)

Ray Deshaies                      (Senior Vice President, Global Research, Amgen, Thousand Oaks, CA, USA)

Michel Desjardins               (University of Montreal, Canada)

Boro Dropulić                     (Executive Director of Caring Cross and CEO of Vector BioMed, Gaithersburg, MD, USA)

Ivana Gašić                         (University of Geneva, Switzerland)

Andrea Gelemanovic         (MedILS, Split, Croatia)

Thomas Jentsch                (Max Delbrück Centre for Molecular Medicine, Berlin, Germany)

Tony Kossiakoff                (University of Chicago, IL, USA)

Thomas Lemberger           (EMBO, Heidelberg, Germany)

Robbie Loewith                 (University of Geneva, Switzerland)

Nika Pintar                         (AniBiome, Zagreb, Croatia)

Kristijan Ramadan            (University of Oxford, UK)

Jürgen Reinhardt              (Director, Novartis Pharma, Basel, Switzerland)

Elisabetta Rubini              (Sapienza University of Rome, Italy)

Uwe Sauer                         (ETH Zurich, Switzerland) “EMBO Member” ,'The EMBO Keynote Lecture'

Berend Snijder                  (ETH Zurich, Switzerland)

Lovorka Stojić                   (Barts Cancer Institute, Queen Mary University, London, UK)

Igor Stagljar                       (Donnelly Centre, University of Toronto, Canada and MedILS, Split, Croatia)

John Tallarico                    (Head, Chemical Biology and Therapeutics at Novartis Institutes for BioMedical Research, Cambridge, MA, USA)

Zlatko Trajanoski               (Medical University of Innsbruck, Austria) 

Katarina Trajković             (MedILS, Split, Croatia)

Adrijana Vinter                   (CEO Selvita, Croatia & Global Head of Drug Discovery)

Domagoj Vučić                  (Senior Fellow, Genentech, South San Francisco, CA, USA)

Henning Walczak              (University College London Cancer Institute, London, UK)

Erich Wanker                     (Max Delbrück Centre for Molecular Medicine, Berlin, Germany)